Symtrend, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.symtrend.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Managing Vascular Dementia Risk Factors With SymTrend
Phase 1
- Conditions
- Vascular Dementia
- First Posted Date
- 2018-10-11
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- SymTrend Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03702543
- Locations
- 🇺🇸
Neurology Department, Massachusetts General Hospital, Boston, Massachusetts, United States
Comprehensive Collection, Charting, and Communication System
- Conditions
- Autism
- First Posted Date
- 2009-11-01
- Last Posted Date
- 2011-06-07
- Lead Sponsor
- SymTrend Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT01005953
- Locations
- 🇺🇸
SymTrend, Belmont, Massachusetts, United States
News
No news found